Radiation oncology in the management of HCC. Who and how should be treated.
Join us on 17 June at 05:30 PDT | 08:30 EDT | 14:30 CET | 20:30 UTC+8 for one-hour webinar on radiation [...]
Read moreNASH limits anti-tumour surveillance in immunotherapy-treated HCC.
This is the report of a preclinical and clinical work assessing the potential correlation between [...]
Read moreSecond-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
This is the report of a phase 3 study assessing the efficacy and safety of FOLFOX in patients with [...]
Read more
Join us at #ILCA21
So much has happened in two years since our last in-person Annual Conference in Chicago. Exhibits and [...]
Read more
Become Part of the Young Investigators Committee
We are thrilled to announce that the call for applications to compose the Young Investigators Steering [...]
Read more
Call for Abstracts Extended – Enjoy your Easter!
We would like to contribute for a peaceful Easter weekend and help you put all your eggs in one basket. [...]
Read moreLiver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
Background: Indications for liver transplantation for hepatocellular carcinoma are evolving and so-called [...]
Read moreCell of origin in biliary tract cancers and clinical implications
This is a review focused on recent advances in the histopathological subtyping of biliary tract cancers [...]
Read more